@article{fdi:010042666,
  title = {{W}orld {H}ealth {O}rganization/{HIVR}es{N}et drug resistance laboratory strategy},
  author = {{B}ertognolio, {S}. and {D}erdelinckx, {I}. and {P}arker, {M}. and {F}itzgibbon, {J}. and {F}leury, {H}. and {P}eeters, {M}artine and {S}chuurman, {R}. and {P}illay, {D}. and {M}orris, {L}. and {T}anuri, {A}. and {G}ershy-{D}amet, {G}. {M}. and {N}kengasong, {J}. and {G}ilks, {C}. {F}. and {S}utherland, {D}. and {S}andstrom, {P}.},
  editor = {},
  language = {{ENG}},
  abstract = {{W}ith rapidly increasing access to antiretroviral drugs globally, {HIV} drug resistance ({HIVDR}) has become a significant public health issue, {T}his requires a coordinated and collaborative response from country level to international level to assess the extent of {HIVDR} and the establishment of efficient and evidence-based strategies to minimize its appearance and onward transmission. {I}n parallel with the rollout of universal access to {HIV} treatment, countries are developing protocols based on the recommendations of the {W}orld {H}ealth {O}rganization ({WHO}) to measure, at a population level, both transmitted {HIVDR} and {HIVDR} emerging during treatment. {T}he {WHO} in collaboration with international experts ({HIVR}es{N}et {L}aboratory {W}orking {G}roup), has developed a laboratory strategy, which has the overall goal of delivering quality-assured {HIV} genotypic results on specimens derived from the {HIVDR} surveys. {T}he results will be used to help control the emergence and spread of drug resistance and to guide decision makers on antiretroviral therapy policy at national, regional and global level. {T}he {HIVDR} {L}aboratory {S}trategy developed by the {WHO} includes several key aspects: the formation of a global network of national, regional and specialized laboratories accredited to perform {HIVDR} testing using a common set of {WHO} standard and performance indicators; recommendations of acceptable methods for collection, handling, shipment and storage of specimens in field conditions; and the provision of laboratory technical support, capacity building and quality assurance for network laboratories. {T}he {WHO}/{HIVR}es{N}et {HIVDR} {L}aboratory {N}etwork has been developed along the lines of other successful laboratory networks coordinated by the {WHO}. {A}s of {A}ugust 2007, assessment for accreditation has been conducted in 30 laboratories, covering the {WHO}'s {A}frican, {S}outh-{E}ast {A}sia, {W}estern {P}acific, and the {C}aribbean {R}egions.},
  keywords = {},
  booktitle = {},
  journal = {{A}ntiviral {T}herapy},
  volume = {13},
  numero = {{S}uppl 2},
  pages = {49--57},
  ISSN = {1359-6535},
  year = {2008},
  URL = {https://www.documentation.ird.fr/hor/fdi:010042666},
}